Fatty Liver Disease That is Neither Metabolic nor Alcoholic

Overview

Journal Hum Pathol

Specialty Pathology

Date 2023 Jan 26

PMID 36702356

Authors

Daniela S Allende

David E Kleiner

Affiliations

Soon will be listed here.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. This article aims to summary less common etiologies of fatty liver and their key clinicopathological features.

Citing Articles

NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review.

Sergi C Int J Mol Sci. 2024; 25(15).

PMID: 39126031 PMC: 11313354. DOI: 10.3390/ijms25158462.

Spleen volume is independently associated with non-alcoholic fatty liver disease, liver volume and liver fibrosis.

Helgesson S, Tarai S, Langner T, Ahlstrom H, Johansson L, Kullberg J Heliyon. 2024; 10(8):e28123.

PMID: 38665588 PMC: 11043861. DOI: 10.1016/j.heliyon.2024.e28123.

References

Mohammed S, Aghdassi E, Salit I, Avand G, Sherman M, Guindi M . HIV-positive patients with nonalcoholic fatty liver disease have a lower body mass index and are more physically active than HIV-negative patients. J Acquir Immune Defic Syndr. 2007; 45(4):432-8. DOI: 10.1097/QAI.0b013e318074efe3. View

Alqahtani S, Chami R, Abuquteish D, Vandriel S, Yap C, Kukkadi L . Hepatic ultrastructural features distinguish paediatric Wilson disease from NAFLD and autoimmune hepatitis. Liver Int. 2022; 42(11):2482-2491. DOI: 10.1111/liv.15319. View

Schneider C, Hamesch K, Gross A, Mandorfer M, Moeller L, Pereira V . Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers. Gastroenterology. 2020; 159(2):534-548.e11. DOI: 10.1053/j.gastro.2020.04.058. View

Akhtar M, Mathieson K, Arey B, Post J, Prevette R, Hillier A . Hepatic histopathology and clinical characteristics associated with antiretroviral therapy in HIV patients without viral hepatitis. Eur J Gastroenterol Hepatol. 2008; 20(12):1194-204. DOI: 10.1097/MEG.0b013e328305b9e0. View

Stromeyer F, Ishak K . Histology of the liver in Wilson's disease: a study of 34 cases. Am J Clin Pathol. 1980; 73(1):12-24. DOI: 10.1093/ajcp/73.1.12. View

Ludvigsson J, Elfstrom P, Broome U, Ekbom A, Montgomery S . Celiac disease and risk of liver disease: a general population-based study. Clin Gastroenterol Hepatol. 2006; 5(1):63-69.e1. DOI: 10.1016/j.cgh.2006.09.034. View

Burton B, Balwani M, Feillet F, Baric I, Burrow T, Camarena Grande C . A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency. N Engl J Med. 2015; 373(11):1010-20. DOI: 10.1056/NEJMoa1501365. View

Pilloni L, Lecca S, Van Eyken P, Flore C, Demelia L, Pilleri G . Value of histochemical stains for copper in the diagnosis of Wilson's disease. Histopathology. 1998; 33(1):28-33. DOI: 10.1046/j.1365-2559.1998.00455.x. View

Guindi M . Wilson disease. Semin Diagn Pathol. 2019; 36(6):415-422. DOI: 10.1053/j.semdp.2019.07.008. View

10.

Roberts E, Schilsky M . Diagnosis and treatment of Wilson disease: an update. Hepatology. 2008; 47(6):2089-111. DOI: 10.1002/hep.22261. View

11.

Patel V, Sanyal A . Drug-induced steatohepatitis. Clin Liver Dis. 2013; 17(4):533-46, vii. PMC: 4888072. DOI: 10.1016/j.cld.2013.07.012. View

12.

Begriche K, Massart J, Robin M, Borgne-Sanchez A, Fromenty B . Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. J Hepatol. 2010; 54(4):773-94. DOI: 10.1016/j.jhep.2010.11.006. View

13.

Pavlik L, Regev A, Ardayfio P, Chalasani N . Drug-Induced Steatosis and Steatohepatitis: The Search for Novel Serum Biomarkers Among Potential Biomarkers for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Drug Saf. 2019; 42(6):701-711. DOI: 10.1007/s40264-018-00790-2. View

14.

Hulkova H, Elleder M . Distinctive histopathological features that support a diagnosis of cholesterol ester storage disease in liver biopsy specimens. Histopathology. 2012; 60(7):1107-13. DOI: 10.1111/j.1365-2559.2011.04164.x. View

15.

Merle U, Schaefer M, Ferenci P, Stremmel W . Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut. 2006; 56(1):115-20. PMC: 1856673. DOI: 10.1136/gut.2005.087262. View

16.

Ramesh S, Sanyal A . Hepatitis C and nonalcoholic fatty liver disease. Semin Liver Dis. 2004; 24(4):399-413. DOI: 10.1055/s-2004-860869. View

17.

Gervasoni C, Cattaneo D, Filice C, Galli M . Drug-induced liver steatosis in patients with HIV infection. Pharmacol Res. 2019; 145:104267. DOI: 10.1016/j.phrs.2019.104267. View

18.

Squillace N, Soria A, Bozzi G, Gori A, Bandera A . Nonalcoholic fatty liver disease and steatohepatitis in people living with HIV. Expert Rev Gastroenterol Hepatol. 2019; 13(7):643-650. DOI: 10.1080/17474124.2019.1614913. View

19.

Adinolfi L, Rinaldi L, Guerrera B, Restivo L, Marrone A, Giordano M . NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations. Int J Mol Sci. 2016; 17(6). PMC: 4926337. DOI: 10.3390/ijms17060803. View

20.

Frankowski M, Swierkot J, Gomulkiewicz M, Korman L, Skoczynska M, Starba A . Usefulness of noninvasive diagnostic procedures for assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis. Rheumatol Int. 2021; 42(4):631-638. PMC: 8940880. DOI: 10.1007/s00296-021-05059-z. View